Depreciation of Altimmune, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Altimmune, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Altimmune, Inc. Depreciation for the quarter ending 31 Mar 2025 was $29,000, a 73% decline year-over-year.
  • Altimmune, Inc. annual Depreciation for 2025 was $112,000, a 53% decline from 2024.
  • Altimmune, Inc. annual Depreciation for 2024 was $238,000, a 50% decline from 2023.
  • Altimmune, Inc. annual Depreciation for 2023 was $477,000, a 3.2% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Altimmune, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $112,000 -$126,000 -53% 01 Jan 2025 31 Dec 2025 10-K 06 Mar 2026 2025 FY
2024 $238,000 -$239,000 -50% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2026 2025 FY
2023 $477,000 -$16,000 -3.2% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $493,000 +$93,000 +23% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $400,000 +$100,000 +33% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $300,000 +$60,179 +25% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $239,821 +$21,104 +9.6% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2021 2020 FY
2018 $218,717 +$134,883 +161% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $83,834 +$20,725 +33% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $63,109 -$78,495 -55% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $141,604 -$8,354 -5.6% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2017 2016 FY
2014 $149,958 -$32,529 -18% 01 Jan 2014 31 Dec 2014 10-K 14 Mar 2017 2016 FY
2013 $182,487 -$121,429 -40% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $303,916 -$157,157 -34% 01 Jan 2012 31 Dec 2012 10-K 11 Mar 2015 2014 FY
2011 $461,073 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2014 2013 FY

Altimmune, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $29,000 -$78,000 -73% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $107,000 -$18,000 -14% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $125,000 +$25,000 +25% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $400,000 $100,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $400,000 $131,550 +$51,719 +65% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $348,281 $100,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $348,281 $68,450 +$7,786 +13% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $340,495 $100,000 +$40,495 +68% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $300,000 $79,831 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $100,000 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $60,664 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $59,505 -$1,772 -2.9% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $61,277 +$36,215 +145% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $25,062 +$12,096 +93% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q1 2017 $38,374 $12,966 -$24,735 -66% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $63,109 $47,262 -$80,068 -244% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $143,177 $32,235 -$2,770 -7.9% 01 Jul 2016 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 $145,947 $40,435 +$3,748 +10% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $142,199 $37,701 +$595 +1.6% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q4 2015 $141,604 $32,806 -$3,880 -11% 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 $145,484 $35,005 -$2,120 -5.7% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $147,604 $36,687 +$479 +1.3% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $147,125 $37,106 -$2,833 -7.1% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $149,958 $36,686 -$6,752 -16% 01 Oct 2014 31 Dec 2014 10-K 14 Mar 2017 2016 FY
Q3 2014 $156,710 $37,125 -$7,468 -17% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $164,178 $36,208 -$5,646 -13% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $169,824 $39,939 -$12,663 -24% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $182,487 $43,438 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
Q3 2013 $44,593 -$27,860 -38% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $41,854 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014 2014 Q2
Q1 2013 $52,602 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q3 2012 $72,453 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.